Hyla PF Eye Drop contains Sodium Hyaluronate 0.1% w/v, a viscoelastic agent used primarily for the management of dry eye syndrome and ocular surface disorders. Sodium Hyaluronate is a naturally occurring glycosaminoglycan with excellent water-retaining properties, providing prolonged hydration and lubrication to the corneal and conjunctival epithelium. This formulation is preservative-free, minimizing the risk of ocular irritation and hypersensitivity reactions, making it suitable for patients with sensitive eyes or those requiring frequent administration. Hyla PF Eye Drop helps restore the tear film stability, reduces symptoms such as dryness, burning, irritation, and foreign body sensation, and promotes epithelial healing. It is indicated for use in conditions characterized by tear film insufficiency, including keratoconjunctivitis sicca, postoperative dry eye, contact lens discomfort, and environmental exposure-related dryness. The drop is administered topically, typically one to two drops instilled into the affected eye(s) as needed, with dosage adjusted according to severity and patient response. Due to its biocompatibility and safety profile, Hyla PF Eye Drop is suitable for long-term use. Patients are advised to avoid contamination of the dropper tip and to consult a healthcare professional if symptoms persist or worsen.